Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma

NCT01606345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Valrubicin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]